People with Medicare Part D plans shoulder a share of the cost of their prescription drugs. Under the standard Part D benefit ...

Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

It was a landmark year for medical advancements in 2024, bringing a wave of innovative treatments that promise to reshape ...

A milestone review examining 1.4 million patients worldwide found that those who do not see the same doctor regularly are ...

Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...